The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.
The therapy increases the amount of blood the heart can pump and dramatically improves survival, in what a paper describing the results calls “an unprecedented recovery of cardiac function.”
On November 4, NASA crew and ground-based scientists sent blood cells to the International Space Station to learn why astronauts have a higher risk of blood clots.
Brenda Heaton aims to uncover the complex web of interacting factors that drive oral health inequities, which in turn affect many other health conditions.
University of Utah Health approached a half-billion dollars ($492.3 million) in research funding in fiscal year 2024. 736 principal investigators in the health sciences received 1,876 awards.
Scientists are finding clues for how to treat diabetes and hormone disorders in an unexpected place: a toxin from one of the most venomous animals on the planet.
The new results could ultimately help lead to interventions that spark creative thought or aid people who have mental illnesses that disrupt these regions of the brain.
9.3% of people who get COVID while pregnant will go on to develop long COVID. Common symptoms are fatigue, gastrointestinal issues, and feeling drained or exhausted by routine activities.
Set to open in early 2026, the James LeVoy Sorenson Center for Medical Innovation will place the University of Utah at the forefront of medical device innovation.
Spinocerebellar ataxia 4 is a severe progressive movement disease that can begin as early as the late teens. Now, a multinational research team led by University of Utah researchers has...
